IRIS
BALLABENI, Vigilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.038
EU - Europa 5.425
AS - Asia 2.625
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 24
SA - Sud America 14
OC - Oceania 3
Totale 14.218
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.891
CN - Cina 1.665
FI - Finlandia 1.190
SE - Svezia 1.036
IE - Irlanda 937
UA - Ucraina 686
SG - Singapore 683
IT - Italia 557
DE - Germania 545
TR - Turchia 209
GB - Regno Unito 164
CA - Canada 126
BE - Belgio 64
CI - Costa d'Avorio 57
FR - Francia 56
AT - Austria 49
RO - Romania 46
IN - India 35
CZ - Repubblica Ceca 29
CM - Camerun 25
EU - Europa 24
NL - Olanda 12
ES - Italia 11
PA - Panama 11
RU - Federazione Russa 10
BR - Brasile 6
MX - Messico 6
VN - Vietnam 6
HK - Hong Kong 5
KR - Corea 5
CL - Cile 4
IR - Iran 4
LT - Lituania 4
SC - Seychelles 4
SI - Slovenia 4
DK - Danimarca 3
PH - Filippine 3
PK - Pakistan 3
PL - Polonia 3
PT - Portogallo 3
AU - Australia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
MD - Moldavia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
IM - Isola di Man 1
JM - Giamaica 1
JP - Giappone 1
KH - Cambogia 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 14.218
Salva come PNG Salva come JPEG
Città #
Dublin 936
Chandler 911
Jacksonville 743
Santa Clara 557
Singapore 539
Dearborn 450
Ann Arbor 448
Beijing 339
Ashburn 297
Boardman 288
Nanjing 242
Izmir 194
Princeton 179
Parma 166
Shanghai 160
New York 147
San Mateo 132
Wilmington 127
Toronto 97
Bremen 88
Hebei 83
Helsinki 82
Kunming 78
Jinan 75
Nanchang 75
Shenyang 75
Grafing 64
Brussels 61
Hefei 58
Abidjan 57
Woodbridge 54
Vienna 48
Los Angeles 45
Changsha 42
Guangzhou 42
Tianjin 42
Des Moines 40
Chicago 30
Seattle 29
Fremont 27
Jiaxing 27
Auburn Hills 24
Munich 23
Norwalk 23
Bologna 20
Hangzhou 20
Marseille 20
Pune 20
West Jordan 19
Brno 17
Dallas 16
London 16
Zhengzhou 16
Taiyuan 15
Milan 13
Frankfurt am Main 12
Haikou 12
Timisoara 12
Fuzhou 11
Houston 11
Kocaeli 11
Lanzhou 11
Mestre 11
Ottawa 11
Taizhou 11
Düsseldorf 10
Carpi 9
Lubbock 9
Montréal 9
Ningbo 9
Chengdu 8
Mordano 8
Madrid 7
Modena 7
Nuremberg 7
Palermo 7
Montegaldella 6
Prague 6
Redwood City 6
Xian 6
Borås 5
Brescia 5
Chongqing 5
Faenza 5
Focsani 5
Jinhua 5
Naples 5
Prata Di Pordenone 5
Quzhou 5
Redmond 5
Rockville 5
Rome 5
Tulsa 5
Altidona 4
Augusta 4
Edinburgh 4
Hanoi 4
Hong Kong 4
Hyderabad 4
Lübeck 4
Totale 8.756
Salva come PNG Salva come JPEG
Nome #
1,5-Benzodiazepines Part XIII. Substututed 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines and 4H-imidazo-[1,2-a][ 1,5]benzodiazepin-5-amines as analgesic, anti-inflammatory and/or antipyretic agents with low acute toxicity 252
1,5-Benzodiazepin tricyclic derivatives as analgersic, anti-inflammatory and /or antipyretic agents with very low acute gastrolesivity and toxicity 201
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 198
1,8-Naphthyridines V. Novel N-substituted 5-amino-N,N-diethyl-9-isopropyl [1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamides, as potent anti-inflammatory and/or analgesic agents completely devoid of acute gastrolesivity 157
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 134
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador 128
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 126
Protective Effects of a Protease Inhibitor (Gabexate Mesilate) on Intestinal Ischemia/Reperfusion Injury in Rats 122
2-Aminobenzimidazoles as new potent H3-antagonists 122
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 117
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 115
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 111
Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon “Grosso” essential oil 110
Analgesic properties of benzisothiazole/ benzimidazole derivatives with acidic groups 107
Nuovi potenti agonisti muscarinici oxotremorina-M simili a struttura acetilenica: studio funzionale in vitro 107
Adaptive changes in rat ileum motility induced by mild mesenteric ischemia/reperfusion injury: role of endogenous mediators and reperfusion time 106
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 106
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 105
2,4-Substituted benzopyrano[4,3-d]pyrimidines and benzopyrano[4,3-d]pyrimidin-5-ones: synthesis and antiplatelet activity 102
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. 101
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 100
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 100
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 100
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 99
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 99
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 98
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 98
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 97
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 97
2-Amino-1,2-benzisothiazolin-3-one derivatives as powerful antiplatelet agents 97
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 97
Aminobenzimidazoles as new potent H3-antagonists 97
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. 97
Influence of adenosine in the systemic and local injury caused by mesenteric ischemia-reperfusion in mice 96
R-a-methylhistamine-induced inhibition of gastric acid secretion in pylorus-ligated rats via central histamine H3 receptors 96
Regional differences in motor responsiveness to antimuscarinic drugs in rabbit isolated small and large intestine 95
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 93
Motor responses of rat hypertrophic intestine following chronic obstruction 93
Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies 92
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 92
A New Potent and Selective Histamine H3-Receptor Antagonist, 4(5)-{2-[4(5)-cyclohexylimidazol-2-ylthio]ethyl}imidazole 91
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 90
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 90
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 90
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 89
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 87
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 86
Assessment of intestinal motor responsiveness in an ischemia/reperfusion model in rats 85
CNS access of selected H3-antagonists: ex vivo binding study in rats 85
Influence of Nitric Oxide system in mesenteric ischemia-reperfusion induced injury in mice 85
Farmaci Lassativi e Farmaci Antidiarroici 85
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 85
Plasma concentration and brain penetration of the H3-receptor antagonist Thioperamide in rats 84
Synthesis and pharmacological screening of novel non-acidic gastric-sparing antiinflammatory/antiplatelet agents:5-alkyl/cycloalkylamino substituted 2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines 84
Novel antiplatelet and antithrombotic activities of essential oil from Lavandula hybrida Reverchon "Grosso" 83
Different role of the Histamine H3 Receptor in Vagal-, Betanechol-, Pentagastrin-induced Gastric Acid Secretion in Anaesthetized Rats 83
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 83
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 83
Role of Glutamate- N-methyl-D-Aspartate (NMDA) Receptors in Neuronal Plasticity and Gastrointestinal Transit Delay Induced by Ischemia/Reperfusion in Rats 82
Assessment of intestinal motor responsiveness in an ischemia/reperfusion model in rats 81
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 81
Interactions of new and conventional H3-blockers with non-histaminergic receptors involved in neurogenic and myogenic contractile responses of guinea-pig ileum 81
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 80
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 80
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat 80
Protection by the EPH-EPHRIN System Against Mesenteric Ischemia-Reperfusion Injury 80
Synthesis and functional characterization of novel heterocyclic derivatives related to oxotremorine and oxotremorine-M 79
Functional Studies of New Imidazole H3-Antagonists on Guinea-Pig Isolated Preparations 79
New analogues of oxotremorine and oxotremorine-M: estimation of their in vitro affinity and efficacy at muscarinic receptor subtypes 79
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 79
NEW EPH ANTAGONISTS DISCRIMINATING BETWEEN EPH-AS AND EPH-BS CLASSES 78
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 78
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 78
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 78
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 78
PHARMACOLOGICAL CHARACTERIZATION OF NEW COMPOUNDS AIMED AT INHIBITING EPH-EPHRIN INTERACTION IN GLIOBLASTOMA 76
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 76
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 76
Alterations of intestinal motor responsiveness in a model of mild mesenteric ischemia/reperfusion in rats 76
New potent acethylenic muscarinic agonists related to oxotremorine-M: in vitro functional study 76
5-Alkoxy-2-hydrazino and 5-methoxy-2-amino-5H[1]benzopyrano[4,3-d]pyrimidines: synthesis and pharmacological activity 75
Screening di nuovi agenti antiinfiammatori/antiaggreganti non-acidici: sviluppo di 2-amino-5H-[1]benzopirano[4,3-d]pirimidine 5-alchil/cicloalchilamino sostituite prive di attivita' gastrolesiva 74
Anomalous responses to histamine stimulation of guinea-pig oesophageal muscularis mucosae 74
Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity 74
2-Amino-1,2-benzisothiazolin-3-one Derivatives: Synthesis and Assessment of their Antiplatelet/Spasmolytic Effects 74
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 73
Synthesis and pharmacological evaluation of 2,5-cycloamino-5H-[1]benzopyrano-[4,3-di]pyrimidines endowed with in vitro antiplatelet activity 73
Functional study of the central access of chemical delivery systems developed as g-aminobutyric acid (GABA) prodrugs 73
Anomalous responses to histamine stimulation of guinea-pig oesophageal muscularis mucosae. 73
Sviluppo e caratterizzazione farmacologica di un nuovo potente e selettivo H3-bloccante istaminico non-tioureico 73
Functional comparison between nuvenzepine and pirenzepine on different guinea pig isolated smooth muscle preparations 73
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 73
Novel triazolonaphthyridine derivatives: potent and highly effective agents in the control of inflammation and pain in rodents 72
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 72
Proteinase-Activated Receptor 2 agonist prevents mesenteric ischemia/reperfusion injury in rats: partila involvement of Substance P (SP) and Calcitonin-Gene Related Peptide (CGRP) 71
RESPONSIVENESS OF LONGITUDINAL AND CIRCULAR MUSCLE TO RELAXING MEDIATORS IS DIFFERENTIALLY AFFECTED IN RAT HYPERTROPHIED ILEUM 71
Brain Pharmacokinetics of Non-Imidazole Biphenyl H3 Receptor Antagonists: a Liquid Chromatography/Electrospray-Mass Spectrometry and ex vivo Binding Study in Rats 71
Effects of subacute treatment with benzopyranopyrimidines in hemostasis and experimental thrombosis in mice 71
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 71
Relationship between structure and ex-vivo binding of imidazole H3 antagonists to rat brain H3 receptors 70
Totale 9.290
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.141
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.420 0 0 0 0 0 313 346 60 280 171 81 169
2020/20211.388 25 170 157 21 174 52 183 19 292 47 211 37
2021/20221.034 24 30 25 111 62 85 121 136 41 65 77 257
2022/20233.734 445 375 229 259 385 411 71 213 1.124 40 121 61
2023/20241.332 81 106 45 52 106 348 115 67 49 74 95 194
2024/20251.732 122 227 295 225 367 496 0 0 0 0 0 0
Totale 14.347